Comparing treatments for low amniotic fluid in pregnancy
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests different treatments for low amniotic fluid (oligohydramnios) in pregnant women. It aims to find which treatment works best for women who are also scheduled for a planned C-section.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 26 and 37 weeks pregnant.
- You are under 35 years old.
- You are carrying only one baby and your baby has no major birth defects.
- You have low amniotic fluid (less than 8 cm on ultrasound).
- You are already scheduled for a planned C-section for another reason.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific ultrasound approach can better detect problems with fetal (baby) growth in the later part of pregnancy. It may help identify concerns earlier so your care team can plan the next steps.
This trial tests two different spinal anesthesia techniques to see which one better prevents low blood pressure during planned cesarean delivery. It aims to improve safety and comfort for mothers.
This trial is testing a way to give fluids before C-section to women with severe preeclampsia. It uses an ultrasound measure of the big vein in your belly (the inferior vena cava) to help decide how much fluid is safe, which may reduce complications.
This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.
This trial tests whether a blood-thinning medication, enoxaparin, can improve outcomes for babies diagnosed with intrauterine growth restriction (poor growth) and too little amniotic fluid. It aims to see if treatment leads to better health for the baby at birth.
This trial tests amnioreduction (draining extra fluid) to relieve symptoms of polyhydramnios, a condition where there is too much amniotic fluid in pregnancy. It may help improve comfort and reduce risks for you and your baby.
Hear when a new Oligohydramnios trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.